Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19)

To report on cases presented with combined endophthalmitis and orbital cellulitis as a first presentation of covid-19 infection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Endophthalmitis and Orbital Cellulitis COVID-19 Cellulitis Connective Tissue Diseases Coronaviridae Infections Coronavirus Infections Endophthalmitis Eye Diseases Eye Infections Infections Lung Diseases Nidovirales Infections Orbital Cellulitis Orbital Diseases Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Skin and Connective Tissue Diseases Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Minia university Hospital

Minya, Minya Governorate, 61519, Egypt

About this study

This observation case series study included 5 patients referred to the Ophthalmology Department, Minia University with severe ophthalmic manifestations in the form of combined endophthalmitis and orbital cellulitis. On doing the work-up of covid-19 infection according to the recommendations of Egyptian Ministry of Health, patients proved to be infected by the novel Corona virus. In addition to the Corona work-up, all patients were subjected to full ophthalmological evaluation, ocular ultrasound and orbital CT examination.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with endophthalmitis and orbital cellulitis with covid-19

Exclusion criteria

Patients without endophthalmitis and orbital cellulitis.
Patients with endophthalmitis and orbital cellulitis not having covid-19 infection.

Treatment and study plan

Primary outcomes

Combined Endophthalmitis and Orbital Cellulitis in patients with Novel Coronavirus Disease (COVID-19)

Time frame: baseline

highlight the occurrence of combined endophthalmitis and orbital cellulitis in patients with novel Coronavirus Disease (COVID-19)

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Jul 2, 2020
Registry last updated: Jul 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed